FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Angelo Scanu

Research Profile

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Celina Edelstein; Ditta Pfaffinger; Ming Yang; John S Hill; Angelo M Scanu
Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts.
Ming Yang; Eugene M Chu; Muriel J Caslake; Celina Edelstein; Angelo M Scanu; John S Hill
Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes.
Celina Edelstein; Ditta Pfaffinger; Ethan C Reichert; Diana M Stafforini; Angelo M Scanu
Mouse Plasminogen Has Oxidized Phosphatidylcholine Adducts That Are Not Metabolized by Lipoprotein-Associated Phospholipase A(2) under Basal Conditions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Angelo Scanu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Celina Edelstein; Ditta Pfaffinger; Ming Yang; John S Hill; Angelo M Scanu
Naturally occurring human plasminogen, like genetically related apolipoprotein(a), contains oxidized phosphatidylcholine adducts.
Biochimica et biophysica acta 2010;1801(7):738-45.
2010: Ming Yang; Eugene M Chu; Muriel J Caslake; Celina Edelstein; Angelo M Scanu; John S Hill
Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes.
Biochimica et biophysica acta 2010;1801(2):176-82.
2010: Celina Edelstein; Ditta Pfaffinger; Ethan C Reichert; Diana M Stafforini; Angelo M Scanu
Mouse Plasminogen Has Oxidized Phosphatidylcholine Adducts That Are Not Metabolized by Lipoprotein-Associated Phospholipase A(2) under Basal Conditions.
International journal of molecular sciences 2010;11(12):5339-47.
2009: Carole Ober; Alex S Nord; Emma E Thompson; Lin Pan; Zheng Tan; Darren Cusanovich; Ying Sun; Raluca Nicolae; Celina Edelstein; Daniel H Schneider; Christine Billstrand; Ditta Pfaffinger; Natasha Phillips; Rebecca L Anderson; Binu Philips; Ramakrishnan Rajagopalan; Thomas S Hatsukami; Mark J Rieder; Patrick J Heagerty; Deborah A Nickerson; Mark Abney; Santica Marcovina; Gail P Jarvik; Angelo M Scanu; Dan L Nicolae
Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.
Journal of lipid research 2009;50(5):798-806.
2009: Celina Edelstein; Binu Philips; Ditta Pfaffinger; Angelo M Scanu
The oxidized phospholipids linked to human apolipoprotein(a) do not derive from circulating low-density lipoproteins and are probably of cellular origin.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2009;23(3):950-6.
2009: Antonio J Lepedda; Antonio Cigliano; Gian Mario Cherchi; Rita Spirito; Marco Maggioni; franco carta; Franco Turrini; Celina Edelstein; Angelo M Scanu; Marilena Formato
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries.
Atherosclerosis 2009;203(1):112-8.
2008: Angelo M Scanu; Celina Edelstein
HDL: bridging past and present with a look at the future.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(12):4044-54.
2008: Angelo M Scanu; Ravi Bamba
Niacin and lipoprotein(a): facts, uncertainties, and clinical considerations.
The American journal of cardiology 2008;101(8A):44B-47B.
2005: Celina Edelstein; Mohammed Yousef; Angelo M Scanu
Elements in the C terminus of apolipoprotein [a] responsible for the binding to the tenth type III module of human fibronectin.
Journal of lipid research 2005;46(12):2673-80.
2005: Angelo M Scanu
Lipoprotein(a): Looking ahead.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2005;15(5):331-3.
2005: Lauren A Weiss; Mark Abney; Rodney Parry; Angelo M Scanu; Edwin H Cook; Carole Ober
Variation in ITGB3 has sex-specific associations with plasma lipoprotein(a) and whole blood serotonin levels in a population-based sample.
Human genetics 2005;117(1):81-7.
2004: Angelo M Scanu; Janet Hinman; Ditta Pfaffinger; Celina Edelstein
Successful utilization of lyophilized lipoprotein(a) as a biological reagent.
Lipids 2004;39(6):589-93.
2004: Marilena Formato; Miriam Farina; Rita Spirito; Marco Maggioni; Anna Guarino; Gian Mario Cherchi; Paolo Biglioli; Celina Edelstein; Angelo M Scanu
Evidence for a proinflammatory and proteolytic environment in plaques from endarterectomy segments of human carotid arteries.
Arteriosclerosis, thrombosis, and vascular biology 2004;24(1):129-35.
2003: Celina Edelstein; Ditta Pfaffinger; Janet Hinman; Elizabeth Miller; Gregory M Lipkind; Sotirios Tsimikas; Claes C G Bergmark; Godfrey S Getz; Joseph L Witztum; Angelo M Scanu
Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a).
The Journal of biological chemistry 2003;278(52):52841-7.
2003: Angelo M Scanu
Lp(a) lipoprotein--coping with heterogeneity.
The New England journal of medicine 2003;349(22):2089-90.
2003: Angelo M Scanu
Lipoprotein(a) and the atherothrombotic process: mechanistic insights and clinical implications.
Current atherosclerosis reports 2003;5(2):106-13.
2002: Angelo M Scanu; Janet Hinman
Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels.
Lipids 2002;37(5):439-44.
2001: O Klezovitch; Celina Edelstein; Angelo M Scanu
Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domain.
The Journal of biological chemistry 2001;276(50):46864-9.
2001: O Klezovitch; Angelo M Scanu
Domains of apolipoprotein E involved in the binding to the protein core of biglycan of the vascular extracellular matrix: potential relationship between retention and anti-atherogenic properties of this apolipoprotein.
Trends in cardiovascular medicine 2001;11(7):263-8.
2001: Celina Edelstein; K Nakajima; Ditta Pfaffinger; Angelo M Scanu
Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins.
Journal of lipid research 2001;42(10):1664-70.
2001: Angelo M Scanu
The role of lipoprotein(a) in the pathogenesis of atherosclerotic cardiovascular disease and its utility as predictor of coronary heart disease events.
Current cardiology reports 2001;3(5):385-90.
2001: K Nakajima; Janet Hinman; Ditta Pfaffinger; Celina Edelstein; Angelo M Scanu
Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDL independently of apolipoprotein(a) size.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(7):1238-43.
2001: Angelo M Scanu; K Nakajima; Celina Edelstein
Apolipoprotein(a): structure and biology.
Frontiers in bioscience : a journal and virtual library 2001;6():D546-54.
2001: Celina Edelstein; Janet Hinman; S Marcovina; Angelo M Scanu
Properties of human free apolipoprotein(a) and lipoprotein(a) after either freezing or lyophilization in the presence and absence of cryopreservatives.
Analytical biochemistry 2001;288(2):201-8.
2000: John E Fortunato; Hisham S Bassiouny; RH Song; H Kocharian; Seymour Glagov; Celina Edelstein; Angelo M Scanu
Apolipoprotein (a) fragments in relation to human carotid plaque instability.
Journal of vascular surgery 2000;32(3):555-63.
2000: O Klezovitch; Marilena Formato; Gian Mario Cherchi; Karl H Weisgraber; Angelo M Scanu
Structural determinants in the C-terminal domain of apolipoprotein E mediating binding to the protein core of human aortic biglycan.
The Journal of biological chemistry 2000;275(25):18913-8.
1999: Angelo M Scanu; Celina Edelstein; O Klezovitch
Dominant role of the C-terminal domain in the binding of apolipoprotein(a) to the protein core of proteoglycans and other members of the vascular matrix.
Trends in cardiovascular medicine 1999;9(7):196-200.
1999: Celina Edelstein; S D Shapiro; O Klezovitch; Angelo M Scanu
Macrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biology.
The Journal of biological chemistry 1999;274(15):10019-23.
1999: GM Fless; E W Kirk; O Klezovitch; JY Santiago; Celina Edelstein; Jane Hoover-Plow; Angelo M Scanu
Effect of phospholipase A2 digestion on the conformation and lysine/fibrinogen binding properties of human lipoprotein[a].
Journal of lipid research 1999;40(4):583-92.
1999: I Mochalkin; B Cheng; O Klezovitch; Angelo M Scanu; Alexander Tulinsky
Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Biochemistry 1999;38(7):1990-8.
1998: Angelo M Scanu
Atherothrombogenicity of lipoprotein(a): the debate.
The American journal of cardiology 1998;82(9A):26Q-33Q.
1998: Angelo M Scanu
Proteolytic modifications of lipoprotein(a): potential relevance to its postulated atherothrombogenic role.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 1998;46(8):359-63.
1998: O Klezovitch; Celina Edelstein; L Zhu; Angelo M Scanu
Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin. Implications for the retention of lipoprotein(a) in atherosclerotic lesions.
The Journal of biological chemistry 1998;273(37):23856-65.
1997: Angelo M Scanu; MM Atzeni; Celina Edelstein; Giancarlo Tonolo; Mario Maioli; O Klezovitch
Lipoprotein(a): identification of subjects with a superbinding capacity for fibrinogen.
Clinical genetics 1997;52(5):367-70.
1997: Angelo M Scanu; Celina Edelstein
Learning about the structure and biology of human lipoprotein [a] through dissection by enzymes of the elastase family: facts and speculations.
Journal of lipid research 1997;38(11):2193-206.
1997: Celina Edelstein; J A Italia; Angelo M Scanu
Polymorphonuclear cells isolated from human peripheral blood cleave lipoprotein(a) and apolipoprotein(a) at multiple interkringle sites via the enzyme elastase. Generation of mini-Lp(a) particles and apo(a) fragments.
The Journal of biological chemistry 1997;272(17):11079-87.
1997: E Esper; Seymour Glagov; RB Karp; K K Simonsen; S R Filer; Angelo M Scanu; M E Sand
Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1997;16(4):420-35.
1996: Celina Edelstein; J A Italia; O Klezovitch; Angelo M Scanu
Functional and metabolic differences between elastase-generated fragments of human lipoprotein[a] and apolipoprotein[a].
Journal of lipid research 1996;37(8):1786-801.
1996: O Klezovitch; Celina Edelstein; Angelo M Scanu
Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
The Journal of clinical investigation 1996;98(1):185-91.
1996: O Klezovitch; Angelo M Scanu
Lys and fibrinogen binding of wild-type (Trp72) and mutant (Arg72) human apo(a) kringle IV-10 expressed in E coli and CHO cells.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(3):392-8.
1995: Celina Edelstein; M Mandala; D Pfaffinger; Angelo M Scanu
Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions.
Biochemistry 1995;34(50):16483-92.
1995: O Klezovitch; Angelo M Scanu
Heterogeneity of lipoprotein (a): growing complexities.
Current opinion in lipidology 1995;6(4):223-8.
1995: Angelo M Scanu
Lipoprotein disorders as related to atherosclerotic cardiovascular disease.
The Surgical clinics of North America 1995;75(4):557-67.
1995: Angelo M Scanu; Celina Edelstein
Kringle-dependent structural and functional polymorphism of apolipoprotein (a).
Biochimica et biophysica acta 1995;1256(1):1-12.
1995: K Makino; J W Furbee; Angelo M Scanu; GM Fless
Effect of glycation on the properties of lipoprotein(a).
Arteriosclerosis, thrombosis, and vascular biology 1995;15(3):385-91.
1995: Lindsey A Miles; GM Fless; Angelo M Scanu; P Baynham; M T Sebald; P Skocir; Linda K Curtiss; Eugene G Levin; Jane Hoover-Plow; Edward F Plow
Interaction of Lp(a) with plasminogen binding sites on cells.
Thrombosis and haemostasis 1995;73(3):458-65.
1995: Angelo M Scanu
Identification of mutations in human apolipoprotein(a) kringle 4-37 from the study of the DNA of peripheral blood lymphocytes: relevance to the role of lipoprotein(a) in atherothrombosis.
The American journal of cardiology 1995;75(6):58B-61B.
1995: Angelo M Scanu
Structural and functional polymorphism of lipoprotein(a): biological and clinical implications.
Clinical chemistry 1995;41(1):170-2.
1994: Angelo M Scanu; D Pfaffinger; J C Lee; J Hinman
A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a).
Biochimica et biophysica acta 1994;1227(1-2):41-5.
1994: Angelo M Scanu; Celina Edelstein
Apolipoprotein(a): structural and functional consequences of mutations in kringle type 10 (or kringle 4-37).
Clinical genetics 1994;46(1 Spec No):42-5.
1994: M L Snyder; R V Hay; Peter F Whitington; Angelo M Scanu; GM Fless
Binding and degradation of lipoprotein(a) and LDL by primary cultures of human hepatocytes. Comparison with cultured human monocyte-macrophages and fibroblasts.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(5):770-9.
1994: Eugene G Levin; Lindsey A Miles; GM Fless; Angelo M Scanu; P Baynham; Linda K Curtiss; Edward F Plow
Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(3):438-42.
1994: Angelo M Scanu; D Pfaffinger; Celina Edelstein
Post-prandial Lp(a): identification of a triglyceride-rich particle containing apo E.
Chemistry and physics of lipids 1994;67-68():193-8.
1994: Celina Edelstein; Nicholas O Davidson; Angelo M Scanu
Oleate stimulates the formation of triglyceride-rich particles containing apoB100-apo(a) in long-term primary cultures of human hepatocytes.
Chemistry and physics of lipids 1994;67-68():135-43.
1993: Jane Hoover-Plow; Lindsey A Miles; GM Fless; Angelo M Scanu; Edward F Plow
Comparison of the lysine binding functions of lipoprotein(a) and plasminogen.
Biochemistry 1993;32(49):13681-7.
1993: D Pfaffinger; J Mc Lean; Angelo M Scanu
Amplification of human APO(a) kringle 4-37 from blood lymphocyte DNA.
Biochimica et biophysica acta 1993;1225(1):107-9.
1993: Angelo M Scanu
Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations.
Biochemical pharmacology 1993;46(10):1675-80.
1993: Y Kusumi; Angelo M Scanu; H C McGill; R W Wissler
Atherosclerosis in a rhesus monkey with genetic hypercholesterolemia and elevated plasma Lp(a).
Atherosclerosis 1993;99(2):165-74.
1993: Celina Edelstein; C Fredenrich; J C Schuelke; W E Jensen; Michael D Sitrin; P H Iverius; Angelo M Scanu
Hypoalphalipoproteinemia: postprandial response of subjects with preprandial normotriglyceridemia and hypertriglyceridemia to various diets.
Metabolism: clinical and experimental 1993;42(2):247-57.
1993: A Balciunas; GM Fless; Angelo M Scanu; R A Copeland
Interactions of a fluorescently labeled peptide with kringle domains in proteins.
Journal of protein chemistry 1993;12(1):39-43.
1993: Angelo M Scanu; Lindsey A Miles; GM Fless; D Pfaffinger; JD Eisenbart; E Jackson; Jane Hoover-Plow; T Brunck; Edward F Plow
Rhesus monkey lipoprotein(a) binds to lysine Sepharose and U937 monocytoid cells less efficiently than human lipoprotein(a). Evidence for the dominant role of kringle 4(37).
The Journal of clinical investigation 1993;91(1):283-91.
1992: Matthew J Sorrentino; C Vielhauer; JD Eisenbart; GM Fless; Angelo M Scanu; Ted Feldman
Plasma lipoprotein (a) protein concentration and coronary artery disease in black patients compared with white patients.
The American journal of medicine 1992;93(6):658-62.
1992: Angelo M Scanu; Celina Edelstein; GM Fless; JD Eisenbart; Michael D Sitrin; B Kasawa; J Hinman
Postprandial lipoprotein(a) response to a single meal containing either saturated or omega-3 polyunsaturated fatty acids in subjects with hypoalphalipoproteinemia.
Metabolism: clinical and experimental 1992;41(12):1361-6.
1992: Angelo M Scanu
Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role.
Molecular and cellular biochemistry 1992;113(2):127-31.
1992: Angelo M Scanu
Lipoprotein(a). Link between structure and pathology.
Annals of epidemiology 1992;2(4):407-12.
1992: Angelo M Scanu
Lipoprotein(a). A genetic risk factor for premature coronary heart disease.
JAMA : the journal of the American Medical Association 1992;267(24):3326-9.
1992: Angelo M Scanu
Genetic basis and pathophysiological implications of high plasma Lp(a) levels.
Journal of internal medicine 1992;231(6):679-83.
1992: Z Li; R Gambino; GM Fless; R A Copeland; A J Halfpenny; Angelo M Scanu
Expression and purification of kringle 4-type 2 of human apolipoprotein (a) in Escherichia coli.
Protein expression and purification 1992;3(3):212-22.
1992: Angelo M Scanu
Lp(a): a link between thrombosis and atherosclerosis.
European journal of epidemiology 1992;8 Suppl 1():76-8.
1992: Angelo M Scanu; D Pfaffinger; GM Fless; K Makino; JD Eisenbart; J Hinman
Attenuation of immunologic reactivity of lipoprotein(a) by thiols and cysteine-containing compounds. Structural implications.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1992;12(4):424-9.
1992: M L Snyder; Denise C Polacek; Angelo M Scanu; GM Fless
Comparative binding and degradation of lipoprotein(a) and low density lipoprotein by human monocyte-derived macrophages.
The Journal of biological chemistry 1992;267(1):339-46.
1991: Angelo M Scanu
Lipoprotein(a) as a cardiovascular risk factor.
Trends in cardiovascular medicine 1991;1(7):294-9.
1991: K Makino; Angelo M Scanu
Lipoprotein(a): nonhuman primate models.
Lipids 1991;26(9):679-83.
1991: D Pfaffinger; J Schuelke; C Kim; GM Fless; Angelo M Scanu
Relationship between apo[a] isoforms and Lp[a] density in subjects with different apo[a] phenotype: a study before and after a fatty meal.
Journal of lipid research 1991;32(4):679-83.
1991: L L Levitsky; Angelo M Scanu; S H Gould
Lipoprotein(a) levels in black and white children and adolescents with IDDM.
Diabetes care 1991;14(4):283-7.
1991: Angelo M Scanu
Lp(a) as a marker for coronary heart disease risk.
Clinical cardiology 1991;14(2 Suppl 1):I35-9.
1991: Angelo M Scanu; GM Fless
The apoB 100-apo(a) complex: relation to triglyceride-rich particles.
Advances in experimental medicine and biology 1991;285():295-8.
1991: Angelo M Scanu; L Scandiani
Lipoprotein(a): structure, biology, and clinical relevance.
Advances in internal medicine 1991;36():249-70.
1990: Angelo M Scanu
Lipoprotein(a): a genetically determined cardiovascular pathogen in search of a function.
The Journal of laboratory and clinical medicine 1990;116(2):142-6.
1990: Angelo M Scanu; GM Fless
Lipoprotein (a). Heterogeneity and biological relevance.
The Journal of clinical investigation 1990;85(6):1709-15.
1990: GM Fless; D J Pfaffinger; JD Eisenbart; Angelo M Scanu
Solubility, immunochemical, and lipoprotein binding properties of apoB-100-apo[a], the protein moiety of lipoprotein[a].
Journal of lipid research 1990;31(5):909-18.
1990: M Hummel; Z G Li; D Pfaffinger; L Neven; Angelo M Scanu
Familial hypercholesterolemia in a rhesus monkey pedigree: molecular basis of low density lipoprotein receptor deficiency.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(8):3122-6.
1990: L Neven; A Khalil; D Pfaffinger; GM Fless; E Jackson; Angelo M Scanu
Rhesus monkey model of familial hypercholesterolemia: relation between plasma Lp[a] levels, apo[a] isoforms, and LDL-receptor function.
Journal of lipid research 1990;31(4):633-43.
1989: GM Fless; M L Snyder; Angelo M Scanu
Enzyme-linked immunoassay for Lp[a].
Journal of lipid research 1989;30(5):651-62.
1989: Celina Edelstein; C L Fredenrich; Angelo M Scanu
Familial hypoalphalipoproteinemia: definition of two groups based on plasma triglyceride levels.
Transactions of the Association of American Physicians 1989;102():148-57.
1989: R E Byrne; Angelo M Scanu
Apolipoprotein B-100 of plasma low density lipoproteins undergoes proteolysis by contact activation factors when plasma is treated with dextran sulfate-500-MgCl2.
Journal of lipid research 1989;30(1):109-20.
1988: Angelo M Scanu; A Khalil; L Neven; M Tidore; G Dawson; D Pfaffinger; E Jackson; K D Carey; H C McGill; GM Fless
Genetically determined hypercholesterolemia in a rhesus monkey family due to a deficiency of the LDL receptor.
Journal of lipid research 1988;29(12):1671-81.
1988: Celina Edelstein; M Kaiser; G Piras; Angelo M Scanu
Demonstration that the enzyme that converts precursor of apolipoprotein A-I to apolipoprotein A-I is secreted by the hepatocarcinoma cell line Hep G2.
Archives of biochemistry and biophysics 1988;267(1):23-30.
1988: Angelo M Scanu
Lipoprotein(a). A potential bridge between the fields of atherosclerosis and thrombosis.
Archives of pathology & laboratory medicine 1988;112(10):1045-7.
1988: Angelo M Scanu
Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
Seminars in thrombosis and hemostasis 1988;14(3):266-70.
1988: P J Jones; Angelo M Scanu; DA Schoeller
Plasma cholesterol synthesis using deuterated water in humans: effect of short-term food restriction.
The Journal of laboratory and clinical medicine 1988;111(6):627-33.
1988: Denise C Polacek; R E Byrne; Angelo M Scanu
Modification of low density lipoproteins by polymorphonuclear cell elastase leads to enhanced uptake by human monocyte-derived macrophages via the low density lipoprotein receptor pathway.
Journal of lipid research 1988;29(6):797-808.
1988: J Z Farooqui; R C Wohl; F J Kézdy; Angelo M Scanu
Identification of the active-site serine in human lecithin: cholesterol acyltransferase.
Archives of biochemistry and biophysics 1988;261(2):330-5.
1986: A Khalil; N Bramson; F J Kezdy; E T Kaiser; Angelo M Scanu
Affinity of nonhomologous amphiphilic peptides toward a monoclonal antibody raised against apolipoprotein A-I.
Proteins 1986;1(3):280-6.
1986: Denise C Polacek; R E Byrne; GM Fless; Angelo M Scanu
In vitro proteolysis of human plasma low density lipoproteins by an elastase released from human blood polymorphonuclear cells.
The Journal of biological chemistry 1986;261(5):2057-63.
1984: R E Byrne; Denise C Polacek; J I Gordon; Angelo M Scanu
The enzyme that cleaves apolipoprotein A-II upon in vitro incubation of human plasma high-density lipoprotein-3 with blood polymorphonuclear cells is an elastase.
The Journal of biological chemistry 1984;259(23):14537-43.
1984: Denise C Polacek; R E Byrne; M Burrous; Angelo M Scanu
Factors controlling the release from human blood polymorphonuclear cells in vitro of a proteolytic activity directed against apolipoprotein A-II.
The Journal of biological chemistry 1984;259(23):14531-6.
1984: Celina Edelstein; D Pfaffinger; Angelo M Scanu
Advantages and limitations of density gradient ultracentrifugation in the fractionation of human serum lipoproteins: role of salts and sucrose.
Journal of lipid research 1984;25(6):630-7.
1983: D Pfaffinger; Celina Edelstein; Angelo M Scanu
Rapid isolation of apolipoprotein E from human plasma very low density lipoproteins by molecular sieve high performance liquid chromatography.
Journal of lipid research 1983;24(6):796-800.